Waters exhibits the SYNAPT G2 system at the 18th International Mass Spectrometry Conference in Europe

Waters Corporation (NYSE: WAT) today exhibited for the first time in Europe the Waters((R)) SYNAPT(TM) G2 a system offering scientists greater power, versatility and speed at the 18(th) International Mass Spectrometry Conference (IMSC). Rounding out its display of mass spectrometry (MS) and UltraPerformance Liquid Chromatography (UPLC((R)))/MS systems at IMSC will be Waters Xevo(TM) family of tandem quadrupole and time-of-flight mass spectrometers noted for their ease-of-use and versatility.

"Advancements in mass spectrometry are expanding the boundaries of scientific research," said Brian Smith, Vice President of Mass Spectrometry Business Operations for Waters Division. "Research-grade MS instruments are providing the power and sensitivity researchers need to better understand diseases and devise new therapeutics. At the same time, MS instruments are being used by more scientists than ever for more routine but equally important analyses, such as for pharmaceutical QC and food safety applications. Regardless of the complexity of the application, Waters MS systems provide robust, accurate, high-quality information quickly and easily, so scientists can focus on analytical results, not on the process of obtaining them."

SYNAPT G2 System Offers Scientists Greater Power, Versatility and Speed Demanding Applications

The SYNAPT G2 System is capable of outstanding qualitative and quantitative MS and High Definition MS(TM) (HDMS(TM)) performance. For scientists this means performance in excess of 40,000 FWHM resolution, high sensitivity, a data acquisition rate of 20 spectra/second, exact mass (1 ppm RMS) information and a dynamic range of up to five orders of magnitude. When paired with Waters ACQUITY((R)) UPLC technology, Waters SYNAPT G2 Mass Spectrometer makes maximum use of the power and speed of UPLC.

SYNAPT G2 system offers scientists:

  • the highest, most comprehensive UPLC MS and UPLC MS/MS performance of any available system
  • proven ion mobility technology to enhance sample specificity and definition to enable discoveries that are simply unachievable by conventional mass spectrometers
  • maximum system usability through its implementation of 'Engineered Simplicity'
  • complete system solutions backed by highly-skilled support scientists to ensure customer success
  • an extensive range of interface capabilities to service the broadest range of applications

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds microplastics in blood clots, linking them to higher risk of heart attacks and strokes